Your browser doesn't support javascript.
loading
Incidence and severity of anaphylaxis and hypersensitivity in trials of intravenous pertuzumab plus trastuzumab or the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection for HER2-positive breast cancer.
Swain, Sandra M; Tan, Antoinette R; Gianni, Luca; Kuemmel, Sherko; Dang, Chau T; Schneeweiss, Andreas; O'Shaughnessy, Joyce; Liu, Haiying; Aguila, Christian; Heeson, Sarah; Macharia, Harrison; Yang, Ke; Restuccia, Eleonora; Loibl, Sibylle.
Afiliação
  • Swain SM; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Medstar Health, 20057 - Washington, USA. Electronic address: sms248@georgetown.edu.
  • Tan AR; Solid Tumor and Investigational Therapeutics, Levine Cancer Institute, Atrium Health, 28204 - Charlotte, USA.
  • Gianni L; Medical Oncology, Fondazione Michelangelo, 20154 - Milan, Italy.
  • Kuemmel S; Breast Unit, Kliniken Essen Mitte, 45136 - Essen/DE and Department of Gynecology with Breast Center, Charité - University Medicine Berlin, 10117 - Berlin, Germany.
  • Dang CT; Department of Medicine, Memorial Sloan Kettering Cancer Center, 10065 - New York, USA.
  • Schneeweiss A; National Center for Tumor Diseases, University Hospital and German Cancer Research Center, 69120 - Heidelberg, Germany.
  • O'Shaughnessy J; Baylor University Medical Center, Texas Oncology, US Oncology, 75246 - Dallas, USA.
  • Liu H; Product Development Oncology, Genentech, Inc., 94080 - South San Francisco, USA.
  • Aguila C; Product Development Oncology, F. Hoffmann-La Roche Ltd, 4058 - Basel, Switzerland.
  • Heeson S; Product Development Oncology, Roche Products Limited, AL7 1TW - Welwyn, UK.
  • Macharia H; Data Sciences, F. Hoffmann-La Roche Ltd, 4058 - Basel, Switzerland.
  • Yang K; Portfolio Clinical Safety, F. Hoffmann-La Roche Ltd, 010, Beijing, China.
  • Restuccia E; Product Development Oncology, F. Hoffmann-La Roche Ltd, 4058 - Basel, Switzerland.
  • Loibl S; German Breast Group (GBG), C/o GBG Forschungs GmbH 63263 - Neu-Isenberg/DE and Centre for Haematology and Oncology Bethanien, Frankfurt, Germany.
Eur J Cancer ; 178: 70-81, 2023 01.
Article em En | MEDLINE | ID: mdl-36410207
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Anafilaxia Tipo de estudo: Incidence_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Anafilaxia Tipo de estudo: Incidence_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2023 Tipo de documento: Article